Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 351-360 of 1757 for

Edit search filters
  1. A Study To Evaluate A Resilient Living Program For Patients With Advancer Cancer And Their Caregivers

    Rochester, MN

  2. S1211, Bortezomib, Dexamethasone, And Lenalidomide With Or Without Elotuzumab In Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  3. Study Of DS-8201a In Subjects With Advanced Solid Malignant Tumors

    Jacksonville, FL

  4. Nivolumab After Combined Modality Therapy In Treating Patients With High Risk Stage II-IIIB Anal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Safety And Preliminary Efficacy Of OBT076 In Recurrent/​Metastatic CD205+ Solid Tumors

    Scottsdale/Phoenix, AZ

  6. A Study Of The Drugs Selumetinib Versus Carboplatin/Vincristine In Patients With Neurofibromatosis And Low-Grade Glioma

    Rochester, MN

  7. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Study to Determine Number of Rounds of Plasma Exchange Needed to Decrease Measles Virus Antibodies for Measles Virus Cancer Therapy

    Rochester, MN

  9. Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)

    Rochester, MN

  10. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

    Rochester, MN

.

Mayo Clinic Footer